Use of Computed Tomography and Histopathologic Review for Lung Lesions Produced by the Interaction Between Mycoplasma hyopneumoniae and Fumonisin Mycotoxins in Pigs

Veterinary Pathology

Volumn 50, Issue 6, 2013, Pages 971-979

  Posa R ^a   Magyar, T ^b   Stoev, S D ^c   Glavits R ^d   Donko T ^a   Repa, I ^a   Kovács, Melinda ^a  

^a SZENT ISTVÁN UNIVERSITY   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c TRAKIA UNIVERSITY   (Bulgaria)

^d Autopsy kkt   (Hungary)

Author keywords

computed tomography; fumonisin B1; histopathology; Mycoplasma hyopneumoniae; pig

Indexed keywords

FUMONISIN; FUMONISIN B1; MYCOTOXIN;

ANIMAL; CHEMICALLY INDUCED; COMPUTER ASSISTED TOMOGRAPHY; DISEASE MODEL; DRUG EFFECTS; ISOLATION AND PURIFICATION; LUNG; LUNG EDEMA; MICROBIOLOGY; MYCOPLASMA HYOPNEUMONIAE; MYCOPLASMAL PNEUMONIA OF SWINE; PATHOLOGY; PIG; RADIOGRAPHY; RANDOMIZATION; SWINE DISEASE; VETERINARY;

ANIMALS; DISEASE MODELS, ANIMAL; FUMONISINS; LUNG; MYCOPLASMA HYOPNEUMONIAE; MYCOTOXINS; PNEUMONIA OF SWINE, MYCOPLASMAL; PULMONARY EDEMA; RANDOM ALLOCATION; SWINE; SWINE DISEASES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84884150110     PISSN: 03009858     EISSN: 15442217     Source Type: Journal    
DOI: 10.1177/0300985813480510     Document Type: Article

References (41)

1. Amass SF,Clark LK,van Alstine WG, et al.Interaction of Mycoplasma hyopneumoniae and Pasteurella multocida infections in swine.J Am Vet Med Assoc. 1994;204 (1): 102-107.
2. Baumeister AK,Runge M,Ganter M, et al.Detection of Mycoplasma hyopneumoniae in bronchoalveolar lavage fluids of pigs by PCR.J Clin Microbiol. 1998;36 (7): 1984-1988.
3. Brockmeier SL,Halbur PG,Thacker ELPolymicrobial Disease. Brogden KAGuthmiller JM, ed. Washington, DC: ASM Press; 2002:231-258.
4. Ciprian A,Pijoan C,Cruz T, et al.Mycoplasma hyopneumoniae increases the susceptibility of pigs to Pasteurella multocida pneumonia.Can J Vet Res. 1988;52 (4): 434-438.
5. Clark LK,Armstrong CH,Scheidt AB, et al.The effect of Mycoplasma hyopneumoniae infection on growth in pigs with or without environmental constraints.J Swine Health Prod. 1993;6 (1): 10-14.
6. Desrosiers R.A review of some aspects of the epidemiology, diagnosis, and control of Mycoplasma hyopneumoniae infections.J Swine Health Prod. 2001;9 (5): 233-237.
7. Dutton MF.The African Fusarium/maize disease.Mycotoxin Res. 2009;25 (1): 29-39.
8. Fazekas B,Bajmócy E,Glávits R, et al.Fumonisin B1 contamination of maize and experimental acute fumonisin toxicosis in pigs.Zentralbl Veterinärmed B. 1998;45 (3): 171-181.
9. Fodor J,Kametler L,Kovács M.Practical aspects of fumonisin production under laboratory conditions.Mycotoxin Res. 2006;22 (4): 211-216.
10. Fossum C,Wattrang E,Fuxler L, et al.Evaluation of various cytokines (IL-6, IFN-α, IFN-γ, TNF-α) as markers for acute bacterial infection in swine-a possible role for serum interleukin-6.Vet Immunol Immunopathol. 1998;64 (2): 161-172.
11. Friis N.Some recommendations concerning primary isolation of Mycoplasma suipneumoniae and Mycoplasma flocculare: a survey.Nord Vet Med. 1975;27 (6): 337-339.
12. Gelderblom WCA,Jaskiewicz K,Marasas WFO, et al.Fumonisins-novel mycotoxins with cancer-promoting activity produced by Fusarium moniliforme.Appl Environ Microbiol. 1998;54 (7): 1806-1811.
13. Goodwin RFW,Pomeroy AP,Whittlestone P.Production of enzootic pneumonia in pigs with a mycoplasma.Vet Rec. 1965;77:1247-1249.
14. Halloy DJ,Gustin PG,Bouhet S, et al.Oral exposure to culture material extract containing fumonisins predisposes swine to the development of pneumonitis caused by Pasteurella multocida.Toxicology. 2005;213 ((1-2)): 34-44.
15. Harrison LR,Colvin BM,Greene JT, et al.Pulmonary edema and hydrothorax in swine produced by fumonisin-B1, a toxic metabolite of Fusarium moniliforme.J Vet Diagn Invest. 1990;2 (3): 217-221.
16. Haschek WM,Motelin G,Ness DK, et al.Characterization of fumonisin toxicity in orally and intravenously dosed swine.Mycopathologia. 1992;117 ((1-2)): 83-96.
17. Kametler L,Fodor J,Kovács M, et al.Biomarker in the detection of fumonisin toxicosis in pigs.Acta Agraria Kaposvariensis. 2006;10 (2): 285-291.
18. Lorenzo H,Quesada O,Assuncao P, et al.Cytokine expression in porcine lungs experimentally infected with Mycoplasma hyopneumoniae.Vet Immunol Immunopathol. 2006;109 ((3-4)): 199-207.
19. Mare CJ,Switzer WP.New species: Mycoplasma hyopneumoniae, a causative agent of virus pig pneumonia.Vet Med. 1965;60:841-846.
20. Marin DE,Taranu I,Pascale F, et al.Sex-related differences in the immune response of weaning piglets exposed to low doses of fumonisin extract.Br J Nutr. 2006;95 (6): 1185-1192.
21. Merrill AH,Wang E,Vales TR, et al.Fumonisin toxicity and sphingolipid biosynthesis.Adv Exp Med Biol. 1996;392:297-306.
22. Oswald IP,Desautels C,Laffitte J, et al.Mycotoxin fumonisin B1 increases intestinal colonization by pathogenic Escherichia coli in pigs.Appl Environ Microbiol. 2003;69 (10): 5870-5874.
23. Pósa R,Donkó T,Bogner P, et al.Interaction of Bordetellabronchiseptica, Pasteurellamultocida and fumonisin B1 in the porcine respiratory tract followed up by computed tomography.Can J Vet Res. 2011;75 (3): 176-183.
24. Rafai P,Bata Á,Ványi A, et al.Effects of various levels of T-2 toxin on the clinical status, performance and metabolism of growing pigs.Vet Rec. 1995;136 (19): 485-489.
25. Ramos CM,Martinez EM,Carrasco AC, et al.Experimental trial of the effect of fumonisin B1 and the PRRS virus in swine.J Anim Vet Adv. 2010;9 (9): 1301-1310.
26. Redondo E,Masot AJ,Fernández A, et al.Histopathological and immunohistochemical findings in the lungs of pigs infected experimentally with Mycoplasma hyopneumoniae.J Comp Path. 2009;140 (4): 260-270.
27. Rotter BA,Thompson BK,Prelusky DB, et al.Response of growing swine to dietary exposure to pure fumonisin B1 during an eight-week period: growth and clinical parameters.Nat Toxins. 1996;4 (1): 42-50.
28. Shibata I,Okada M,Urono K, et al.Experimental dual infection of cesarean-derived, colostrum-deprived pigs with Mycoplasma hyopneumoniae and pseudorabies virus.J Vet Med Sci. 1998;60 (3): 295-300.
29. Sibila M,Pieters M,Molitor T, et al.Current perspectives on the diagnosis and epidemiology of Mycoplasma hyopneumoniae infection.Vet J. 2009;181 (3): 221-231.
30. Sitjar M,Noyes EP,Simon X, et al.Relationships among seroconversion to Mycoplasma hyopneumoniae, lung lesions, and production parameters in pigs.Swine Health Prod. 1996;4 (6): 273-277.
31. Stoev SD,Denev S,Dutton MF, et al.Complex etiology and pathology of mycotoxic nephropathy in South African pigs.Mycotox Res. 2010;26 (1): 31-46.
32. Stoev SD,Dutton M,Njobeh P, et al.Mycotoxic nephropathy in Bulgarian pigs and chickens: complex aetiology and similarity to Balkan endemic nephropathy.Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2010;27 (1): 72-88.
33. Stoev SD,Gundasheva D,Zarkov I, et al.Experimental mycotoxic nephropathy in pigs provoked by a mouldy diet containing ochratoxin A and fumonisin B1.Exp Toxicol Pathol. 2012;64 ((7-8)): 733-741.
34. Taranu I,Marin DE,Bouhet S, et al.Mycotoxin fumonisin B1 alters the cytokine profile and decreases the vaccinal antibody titer in pigs.Toxicol Sci. 2005;84 (2): 301-307.
35. Thacker EL,Halbur PG,Ross RF, et al.Mycoplasma hyopneumoniae potentiation of porcine reproductive and respiratory syndrome virus-induced pneumonia.J Clin Microbiol. 1999;37 (3): 620-627.
36. Thacker EL,Thacker BJ,Janke BH.Interaction between Mycoplasma hyopneumoniae and swine influenza virus.J Clin Microbiol. 2001;39 (7): 2525-2530.
37. Thacker ELDiseases of Swine. Straw BZimmermann JD'Allaire S, ed. Ames: Iowa State University Press; 2006:701-717.
38. Tóth Á,Zomborszky-Kovács M,Tornyos G, et al.Effect of low doses of the mycotoxin fumonisin B1 on the body weight gain, feed intake and feed conversion rate of pigs.Agriculture. 2000;6 (2): 149-151.
39. Yagihashi T,Nunoya T,Mitui T, et al.Effect of Mycoplasma hyopneumoniae infection on the development of Haemophilus pleuropneumoniae pneumonia in pigs.Jpn J Vet Sci. 1984;46 (5): 705-713.
40. Zomborszky-Kovács M,Vetési F,Repa I, et al.Experiment to determine limits of tolerance for fumonisine B1 in weaned piglets.J Vet Med B. 2000;47 (4): 277-286.
41. Zomborszky-Kovács M,Kovács F,Horn P, et al.Investigations into the time- and dose-dependent effect of fumonisin B1 in order to determine tolerable limit values.Liv Prod Sci. 2002;76 (3): 251-256.